Can IGFBPL1 therapeutics effectively cross the blood-brain barrier to reach CNS microglia?

PARTIALLY ADDRESSED

The debate highlighted IGFBPL1's potential as a microglial master regulator but identified a critical gap in delivery mechanisms. Without resolving BBB penetration, the therapeutic hypothesis remains untestable despite promising preclinical evidence. Source: Debate session sess_SDA-2026-04-04-gap-neuro-microglia-early-ad-20260404 (Analysis: SDA-2026-04-04-gap-neuro-microglia-early-ad-20260404)

Priority: 0.90 Domain: drug-delivery Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: Can IGFBPL1 therapeutics effectively cross the blood-brain barrier to reach CNS microglia? is a 0.9 priority gap in drug-delivery. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Can IGFBPL1 therapeutics effectively cross the blood-brain barrier to reach CNS microglia? — INVOKE-2 (completed)

📈 Living Dashboards

0

Hypotheses

0.000

Top Score

0.000

Avg Score

0

Debates

0.00

Avg Quality

60%

Resolution

0

Mechanistic Families

Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (4)

venglustat→CNStherapeutic agents→CNSACY-738→CNSIGFBPL1→neurodegeneration

associated with microglial priming (1)

IGFBPL1→Alzheimer's disease

co associated with (11)

DNMT3A, HDAC1/2→IGFBPL1IGFBPL1→IL1B, TNFA, NLRP3C1QA, C3, CX3CR1, CX3CL1→IGFBPL1CLOCK, ARNTL→IGFBPL1GPR43, GPR109A→IGFBPL1

▸ Show 6 more

HIF1A, NFKB1→IGFBPL1IGFBPL1→TNF/IL6APOE→IGFBPL1IGFBPL1→MultipleIGFBPL1→TREM2C1QA→IGFBPL1

describes (1)

cell-types-nodes-ranvier-neurod→CNS

expressed in (3)

BDNF→CNSMICROGLIA→CNSDAM→CNS

infects (1)

inhibits (2)

IGFBPL1→neuroinflammationEliglustat→CNS

is expressed outside (1)

is the primary lipid carrier within (1)

mediates (1)

penetrate (1)

prevents (2)

IGFBPL1→tau_pathologyIGFBPL1→neuroinflammation

regulates (3)

MS→CNSperipheral immune system→CNSIGFBPL1→microglial_homeostasis

targets (2)

h-d4ff5555→IGFBPL1h-6880f29b→IGFBPL1

🕑 Activity Feed

✏ update on knowledge_gap by None 2026-04-21T14:21

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps